Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.7%

2 terminated out of 30 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

17%

5 trials in Phase 3/4

Results Transparency

14%

3 of 22 completed with results

Key Signals

3 with results92% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (13)
P 1 (2)
P 2 (3)
P 3 (1)
P 4 (4)

Trial Status

Completed22
Unknown3
Recruiting2
Terminated2
Withdrawn1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT00001230Recruiting

Host Response to Infection and Treatment in Filarial Diseases

NCT00001406Recruiting

Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia

NCT03014167Phase 3CompletedPrimary

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)

NCT05048485Completed

Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets

NCT06497075CompletedPrimary

Co-administration of IVM and ALB in School-based Deworming in Uganda

NCT02420574Not ApplicableCompletedPrimary

Assessment of Drug Efficacy of Local Albendazole

NCT04041427Not ApplicableCompletedPrimary

Urine Albendazole Levels for Coverage Assessment

NCT04041453Phase 2Completed

Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients

NCT04227925CompletedPrimary

The Longevity of Trichuris Trichiura Colonization

NCT04227834Not ApplicableUnknownPrimary

Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education

NCT00004996Completed

Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections

NCT02636803Phase 2WithdrawnPrimary

Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults

NCT02362932Not ApplicableCompleted

The Effect of an Urban Sanitation Intervention on Child Health

NCT02397772Phase 4CompletedPrimary

Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya

NCT03173742Phase 1CompletedPrimary

Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)

NCT02396407Not ApplicableCompletedPrimary

Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health

NCT02725255Phase 2CompletedPrimary

Design and Clinical Evaluation of a School Meal With Deworming Properties

NCT02385058Phase 4CompletedPrimary

Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

NCT01368354Not ApplicableCompleted

Taenia Solium Control Case Study in Zambia

NCT00507221Not ApplicableCompleted

Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

Scroll to load more

Research Network

Activity Timeline